FDA Approves New Dosage Strength of Buprenorphine and Naloxone Sublingual Film as Maintenance Treatment for Opioid Dependence

Article Excerpt: The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence.

Full Article: https://tinyurl.com/ybaubfxu

Article Source: FDA

Posted in: Emerging Technologies, News, Regulation & Policy // Tagged: addiction; development; FDA; opioid epidemic; policy and regulation; treatment

FDA Approves New Dosage Strength of Buprenorphine and Naloxone Sublingual Film as Maintenance Treatment for Opioid Dependence

Share